Aim-To determine which, if any, of five commercially available desmin clones is most reliable at labelling desmin filaments and whether the enhanced polymer one step (EPOS) method of labelling is of any advantage in the routine diagnostic laboratory. Methods-Thirty four rhabdomyosarcomas from the files at The Hospital for Sick Children, Great Ormond Street, London, were studied. Four different desmin clones, DE-R-11, D33, DE-U-10, and PDE, were applied to each using the conventional extravidin biotin peroxidase method. The D33 clone was also applied using the EPOS method. 
Tumours of skeletal and smooth muscle may pose difficulties in diagnosis. Desmin The slides were washed in phosphate buffered saline (PBS) and incubated with either 'IX.
. . . All of the slides were examined by two independent observers and coded such that the observers did not know which antibody had been applied. The slides were scored according to percentage of tumour cells labelled. 15 Most biopsy specimens of small round cell tumours of childhood are small and therefore the antibody which reliably labels most cells is the most valuable for diagnosis. From the results of our study, although there was no significant difference in the number of positively labelled cases with the routine extravidin biotin peroxidase technique between the different antibodies, there was a difference in the groups of cells that the different desmin clones labelled-that is, two different clones may both be positive but due to labelling of different rhabdomyosarcoma cells. This means that in a small biopsy specimen there is a greater chance of identifying desmin positive cells if two different clones are used.
The most striking difference in labelling was that between the routine method and the EPOS method. Four of the cases which were negative on staining with all antibodies by the routine method were positive with D33 EPOS, an important finding as a desmin negative result may suggest a diagnosis other than rhabdomyosarcoma.
As fig 1 clearly shows, D33 EPOS had the least number of negatively labelled cases and the greatest number ofpositively labelled cases. This difference was sustained not only against the different desmin clones but also against the same D33 clone using the routine labelling method. Therefore, the clone is not more sensitive but the technique permits greater antigen retrieval. To test the hypothesis that D33 EPOS is significantly better at labelling desmin than the other groups, we applied the y2 test which gave p<0-001.
DE-U-10 and D33 were the only two antibodies that produced negative results, in four and two cases, respectively, when all of the others were positive. However, D33 did have the second highest score for 46% or more positively labelled cells.
The two main advantages of the EPOS method with desmin antibodies are (1) in a small biopsy sample there is a greater chance of picking up positive cells and (2) the result is obtained much faster. The routine method takes about four to fivehours from the time appropriately dried sections are available, whereas the EPOS method takes about one and a half hours. The latter method is also much simpler, titrations are not required and so can be performed by someone with less specialised training. The time saving and the saving of highly qualified staff offsets the extra expense of the EPOS kits, which cost approximately £2.00 per slide.
We conclude that with the routine method desmin clones labelled the same overall number of rhabdomyosarcoma cases but the cases labelled were different and therefore for the greatest chance of accurately assessing the muscle of origin of a tumour, more than one clone should be used. The EPOS method for detecting desmin is fast and accurate with significantly more cells being labelled than with the routine extravidin biotin technique. If only
